Correction: infant malaria antibody guidance and procurement claim is unsubstantiated
The cited announcement could not be verified; clinical research and a WHO policy decision are distinct.
Article subject labels can be suggestions and are not editorial confirmation.
The cited announcement could not be verified; clinical research and a WHO policy decision are distinct.
Existing WHO initiatives do not establish the claimed new network, laboratory timetable or data-sharing system.
A dated WHO evidence review does not establish the reported decision or a uniform outcome.
An earlier WHO diagnostic initiative does not establish the claimed device, performance or purchasing commitments.
Earlier WHO evidence considerations do not establish the reported new decision or trial programme.
WHO evaluates household water-treatment performance; that does not verify the specific UVC device or universal safety claim.
A documented technology-transfer programme does not establish the claimed universal validation or certification.
Existing influenza surveillance does not establish the claimed new platform or uniform test times.
The original report is withdrawn pending verification. On 15 September 2026 an IEEE task force announced that responses to comments on its P802.3dj draft had been posted. On 11 November the IEEE standards page still described P802.3dj, which includes 1.6 Tb/s Ethernet, as a draft with an active project authorization; that authorization is not final standard approval.
The original report is withdrawn pending verification. On 20 May 2023 WHO and partners announced the launch of the International Pathogen Surveillance Network, a collaboration to strengthen pathogen genomics and public health decisions. Its existence does not verify the reported new November 2026 activation or a guarantee of real-time worldwide coverage.
Institut Universitaire du Cancer de Toulouse in France has certified advanced operational capabilities in science, reinforcing infrastructural resilience and technological leadership.
Instituto Butantan Research Laboratories in Brazil has certified advanced operational capabilities in science, reinforcing infrastructural resilience and technological leadership.